Edward J. Schenck, MD

Assistant Professor of Medicine

Pulmonary Medicine and Critical Care (Medicine)

Contact & profiles

Appointments

Assistant Professor of MedicinePrimary
Medicine · 2021–
Assistant Professor of Population Health Sciences
Population Health Sciences · 2025–
Assistant Professor
Weill Cornell Graduate School — Clinical & Translational Investigation · 2025–
Physician
NewYork-Presbyterian Hospital

Past Appointments

Show all 4

Centers

Education

Highlights

1
Journal of biomedical informatics · 2021
EJEdward J. Schenck ESEvan Sholle TCThomas Campion
PMID: 33862230PMCID: PMC8187305DOIFirst author25 citations
2
Scientific reports · 2021
JCJustin Choi ZZZhen Zhao SRSabrina Racine-Brzostek HSHe Sarina Yang+2 more →EJEdward J. Schenck
PMID: 34131192PMCID: PMC8206105DOISenior author40 citations
3
Open forum infectious diseases · 2023
RPRosy Priya L Kodiyanplakkal EJEdward J. Schenck
PMID: 37056981PMCID: PMC10086309DOISenior author19 citations

112

6 grants

MPI
The COvid and Diabetes Assessment (CODA) Study
National Institute of Diabetes and Digestive and Kidney Diseases · 2023–2027 · via Vanderbilt University Medical Center
U01DK137533-04
MPI
Long-term impacts of early COVID-19 related healthcare disruptions on cardiovascular health disparities among patients with multiple chronic condition
National Institute on Aging · 2022–2027 · via New York University
R01AG073321-01A1
MPI
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
National Institute on Aging · 2019–2026 · via Duke University
U19AG065188-01
Sub-PI
Advancing Public Health Use of Electronic Health Record Data
Centers for Disease Control and Prevention · 2025–2026 · via The Task Force for Global Health, Inc.
NU38PW000002-02-01
PI
Necroinflammatory Cell Death in Sepsis
National Heart, Lung, and Blood Institute · 2021–2026Career
K23HL151876-05
Sub-PI
Cell-free DNA as a versatile analyte for the monitoring of sepsis
National Institute of Allergy and Infectious Diseases · 2023–2026 · via Cornell University - Ithaca
R21AI173979-01A1

Completed grants (1)

MPI
Clinical and Translational Science Center - KL2
National Center for Advancing Translational Sciences · 2017–2022Career
KL2TR002385-01

6 studies

PI
Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)
PHASE2 · Biomedical Advanced Research and Development Authority · OPEN TO ACCRUAL (as of 2026)
Acute Respiratory Distress Syndrome (ARDS); ARDS; ARDS (Acute Respiratory Distress Syndrome); Acute Respiratory Distress Syndrome
NCT06701669
PI
Lipid mediators in influenza infection
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
PI
Cell-free DNA as a versatile analyte for the monitoring of sepsis
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
PI
Studying, improving, and evaluating sepsis electronic clinical decision support systems and sepsis quality improvement
Columbia University · OPEN TO ACCRUAL (as of 2023)
PI
Necroinflammatory Cell Death in Sepsis
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2022)
PI
Data analysis of SARS-CoV2 critical illness
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)

Completed & closed trials (2)

PI
A Phase Ib Trial of Inhaled Carbon Monoxide for the Treatment of Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
PHASE1 · Mass General Brigham Inc. · CLOSED TO ACCRUAL (as of 2024)
Acute Respiratory Distress Syndrome; Sepsis
NCT04870125
PI
The Weill Cornell Registry of SARS-CoV 2 Patients
Partners Healthcare · CLOSED TO ACCRUAL (as of 2021)